CM

CM Management Portfolio holdings

AUM $110M
This Quarter Return
+2.85%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
10 Year Return
AUM
$138M
AUM Growth
+$138M
Cap. Flow
+$1.98M
Cap. Flow %
1.43%
Top 10 Hldgs %
35.89%
Holding
98
New
17
Increased
24
Reduced
4
Closed
13

Sector Composition

1 Healthcare 36.58%
2 Financials 14.24%
3 Technology 13.07%
4 Energy 11.74%
5 Materials 7.65%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TRC icon
51
Tejon Ranch
TRC
$454M
$1.07M 0.77%
70,000
ACNB icon
52
ACNB Corp
ACNB
$470M
$949K 0.69%
34,000
CTXS
53
DELISTED
Citrix Systems Inc
CTXS
$938K 0.68%
+8,000
New +$938K
ICPT
54
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$899K 0.65%
+45,000
New +$899K
EQT icon
55
EQT Corp
EQT
$32.2B
$890K 0.64%
40,000
+15,000
+60% +$334K
TVTX icon
56
Travere Therapeutics
TVTX
$1.75B
$875K 0.63%
60,000
+28,000
+88% +$408K
DISCK
57
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$869K 0.63%
+30,000
New +$869K
NKTR icon
58
Nektar Therapeutics
NKTR
$543M
$858K 0.62%
50,000
SMSI icon
59
Smith Micro Software
SMSI
$15.2M
$835K 0.6%
160,000
MTG icon
60
MGIC Investment
MTG
$6.47B
$816K 0.59%
60,000
USAP
61
DELISTED
Universal Stainless & Alloy
USAP
$795K 0.57%
+78,542
New +$795K
WBA
62
DELISTED
Walgreens Boots Alliance
WBA
$789K 0.57%
+15,000
New +$789K
HRTX icon
63
Heron Therapeutics
HRTX
$204M
$776K 0.56%
50,000
ATER icon
64
Aterian
ATER
$9.56M
$732K 0.53%
50,000
+10,000
+25% +$147K
TBPH icon
65
Theravance Biopharma
TBPH
$691M
$726K 0.52%
50,000
CRTD
66
DELISTED
Creatd Inc. Common Stock
CRTD
$713K 0.52%
190,000
+115,000
+153% +$432K
CBAY
67
DELISTED
Cymabay Therapeutics
CBAY
$654K 0.47%
150,000
FLXN
68
DELISTED
Flexion Therapeutics, Inc.
FLXN
$617K 0.45%
75,000
OGN icon
69
Organon & Co
OGN
$2.56B
$605K 0.44%
+20,000
New +$605K
PLPC icon
70
Preformed Line Products
PLPC
$934M
$594K 0.43%
8,000
ELDN icon
71
Eledon Pharmaceuticals
ELDN
$155M
$593K 0.43%
75,000
PAAS icon
72
Pan American Silver
PAAS
$12.3B
$571K 0.41%
+20,000
New +$571K
SRCE icon
73
1st Source
SRCE
$1.57B
$558K 0.4%
12,000
BCEL
74
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$511K 0.37%
60,000
VYNE icon
75
VYNE Therapeutics
VYNE
$8.09M
$505K 0.37%
143,750